Information  X 
Enter a valid email address

EPIC/TIDM matching '0QSS'

Date
Time Source
Company
Announcement
17 Sep 2019 10:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2019
11 Sep 2019 10:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host Second Quarter 2019 Conference Call and Business Update
03 Sep 2019 4:51 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2019
02 Aug 2019 4:45 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2019
16 Jul 2019 9:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 21, 2019
02 Jul 2019 5:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2019
26 Jun 2019 10:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Enrollment of First Patient in Phase 2 Clinical Trial Evaluating Eryaspase in TNBC
24 Jun 2019 10:30 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies
  6:30 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Opening of Operations at its New Princeton, NJ GMP Manufacturing Facility
31 May 2019 5:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 21, 2019
13 May 2019 9:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States
06 May 2019 8:30 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Financial Results for First Quarter 2019
  6:30 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH proposes the appointment of Dr. Jean-Paul Kress as Chairman of the Board of Directors
02 May 2019 8:30 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host on May 7, 2019 First Quarter Conference Call and Business Update
02 Apr 2019 5:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2019
01 Apr 2019 8:30 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Presents New Erymethionase Preclinical Findings at the 2019 AACR Annual Meeting
29 Mar 2019 7:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Filing of 2018 “Document de Référence” and 2018 Annual Report on Form 20-F
12 Mar 2019 5:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2019
11 Mar 2019 9:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Financial Results for Full Year 2018
  6:30 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Presents Findings at European Red Cell Research Society Meeting
08 Mar 2019 6:30 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Present at Cowen & Company 39th Annual Healthcare Conference Meeting
06 Mar 2019 6:30 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host Fourth Quarter and Full Year 2018 Conference Call and Business Update
06 Feb 2019 4:45 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2019
18 Jan 2019 6:00 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting
08 Jan 2019 5:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2018
05 Dec 2018 5:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2018
15 Nov 2018 9:05 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research
12 Nov 2018 9:30 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Reports Third Quarter 2018 Financial Results and Provides Business Update
05 Nov 2018 5:00 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2018
  6:00 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host KOL Breakfast Symposium with Audio Webcast on November 7, 2018
20 Sep 2018 6:30 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Enrollment of First Patients in Phase 3 Clinical Trial Evaluating Eryaspase for the Treatment of Second Line Pancreatic Cancer
13 Sep 2018 6:30 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Attend Upcoming Investor Conferences
10 Sep 2018 9:30 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update
06 Sep 2018 6:30 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host Second Quarter 2018 Conference Call and Business Update
17 Jul 2018 9:30 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018
24 Jun 2018 11:06 pm GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia
20 Jun 2018 6:30 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Present at JMP Securities Life Science Conference
15 Jun 2018 6:31 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Present Preclinical and Clinical Data on Use of Eryaspase in ALL and AML at EHA 2018
07 Jun 2018 6:30 am GNW   Factsheet Erytech Pharma S.A. (0QSS) Erytech Pharma S.A. : General Meeting to be held on June 28, 2018 and Availability of Related Materials
04 Jun 2018 6:30 am GNW   Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Present Pharmacodynamic Data from Phase 2/3 Trial of Eryaspase in ALL at ASCO 2018


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t